I told my editor that writing the worst CEOs of biopharma column is one of my most enjoyable work assignments every year. Does that make me a mean, vindictive person? I don’t think so, it’s just fun.
This is a column that needs no introduction. Here are the CEOs who committed blunders or offenses in 2020 egregious enough to land on my naughty list. I have no personal animus against any of these individuals. I hope they all rebound and accomplish spectacular things in 2021.
Why only three on the voting list? I think Nader Pourhassan, CytoDyn should have it by a landslide.
Comments are closed.